A software defect could cause the app to terminate, resulting in missed alerts or alarms. Dexcom required users to update the app.
Dexcom G6 was the first Continuous Glucose Monitoring (CGM) System to be officially listed by the NIHB Drug Benefit program. BURNABY, British Columbia--(BUSINESS WIRE)--Dexcom, Inc. (NASDAQ: DXCM), ...
The Non-Insured Health Benefits (NIHB) program establishes exemplary coverage for Dexcom’s real-time continuous glucose monitoring system – bringing game-changing technology to more First Nations and ...
SINGAPORE--(BUSINESS WIRE)--Dexcom, Inc. (NASDAQ:DXCM), a global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, announced today the launch of its Dexcom G6 CGM ...
Dexcom has been hit by a major safety issue for an Android version of its G6 continuous monitoring system app, leading the FDA to issue its most serious recall notice. | Dexcom has been hit by a major ...
The Dexcom G6 and Abbott FreeStyle Libre are two of the top continuous glucose monitors (CGMs). Each glucose monitor offers different features and has its own pros and cons. Share on Pinterest ...
Dexcom’s G6 Continuous Glucose Monitoring system will soon be integrated with Livongo’s platform, thanks to a new partnership between the two diabetes-focused companies. G6 users who are also Livongo ...
DexCom, Inc. DXCM, announced that its DexCom G6 continuous glucose monitoring (CGM) system can now connect with the Omnipod 5 Automated Insulin Delivery (AID) system in Germany. The Omnipod 5 AID ...
DexCom, Inc.DXCM announced that its next generation G6 CGM system has received an approval from Health Canada, a regulatory authority. The device is designed to cater to diabetes patients in Canada, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results